Colostrum Whey Protein Attenuates Osteoporosis via Osteogenic Stimulation, Anti-Resorptive Effects, and Hepatic-Bone Axis Modulation

Osteoporosis, a prevalent skeletal disorder aggravated by estrogen deficiency, is a major global health concern that presents significant clinical challenges, particularly for postmenopausal women. This study evaluates the therapeutic potential of colostrum whey protein (CWP) in mitigating estrogen deficiency-induced osteoporosis through both <em>in vivo</em> (ovariectomized murine model) and <em>in vitro</em> (osteoblast culture) approaches. In ovariectomized (OVX) mice, CWP administration increased bone mineral density (BMD) by 45%, elevated trabecular number (Tb.N) by 38%, restored trabecular thickness (Tb.Th), and reduced trabecular separation (Tb.Sp) by 40%. Histomorphometric analysis confirmed enhanced trabecular structure, collagen restoration, and reduced osteoclast activity. CWP also restored bone metabolism by increasing alkaline phosphatase (ALP) and osteoprotegerin (OPG) levels, while decreasing receptor activator of nuclear factor kappa-B ligand (RANKL) and tartrate-resistant acid phosphatase (TRAP) levels. Mechanistic studies showed that CWP modulated the hepatic-bone axis through suppression of PP2ACα and induction of lecithin-cholesterol acyltransferase (LCAT), facilitating cholesterol transport. Furthermore, CWP upregulated osteogenic markers (bone morphogenetic protein-2 (BMP-2), runt-related transcription factor-2 (RUNX-2), and activated MAPK, BMP/Smad, and WNT/β-catenin signaling pathways, promoting osteoblast proliferation, differentiation, and mineralization<em> in vitro</em>. These findings highlight CWP’s dual role in enhancing bone formation and inhibiting resorption through both local (osteoblast activation) and systemic (hepatic-bone axis modulation) mechanisms. Collectively, CWP emerges as a promising multi-target therapeutic candidate for osteoporosis, bridging bone remodeling and metabolic crosstalk. Additional translational studies are warranted to validate its clinical efficacy.

Authors

Publication Details

Journal
Food Science and Human Wellness
Published
2026-01-01
DOI
https://doi.org/10.26599/fshw.2025.9250871
Primary Topic
Animal health and immunology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Colostrum Whey Protein Attenuates Osteoporosis via Osteogenic Stimulation, Anti-Resorptive Effects, and Hepatic-Bone Axis Modulation

Shuzhen Cheng, Guozhi Ji, Lijun You, Xinnuo Wang et al.
Food Science and Human Wellness
Animal health and immunology
article

Colostrum Whey Protein Attenuates Osteoporosis via Osteogenic Stimulation, Anti-Resorptive Effects, and Hepatic-Bone Axis Modulation

Shuzhen Cheng, Guozhi Ji, Lijun You, Xinnuo Wang, Mati Ullah Khan
article en

Abstract

Osteoporosis, a prevalent skeletal disorder aggravated by estrogen deficiency, is a major global health concern that presents significant clinical challenges, particularly for postmenopausal women. This study evaluates the therapeutic potential of colostrum whey protein (CWP) in mitigating estrogen deficiency-induced osteoporosis through both <em>in vivo</em> (ovariectomized murine model) and <em>in vitro</em> (osteoblast culture) approaches. In ovariectomized (OVX) mice, CWP administration increased bone mineral density (BMD) by 45%, elevated trabecular number (Tb.N) by 38%, restored trabecular thickness (Tb.Th), and reduced trabecular separation (Tb.Sp) by 40%. Histomorphometric analysis confirmed enhanced trabecular structure, collagen restoration, and reduced osteoclast activity. CWP also restored bone metabolism by increasing alkaline phosphatase (ALP) and osteoprotegerin (OPG) levels, while decreasing receptor activator of nuclear factor kappa-B ligand (RANKL) and tartrate-resistant acid phosphatase (TRAP) levels. Mechanistic studies showed that CWP modulated the hepatic-bone axis through suppression of PP2ACα and induction of lecithin-cholesterol acyltransferase (LCAT), facilitating cholesterol transport. Furthermore, CWP upregulated osteogenic markers (bone morphogenetic protein-2 (BMP-2), runt-related transcription factor-2 (RUNX-2), and activated MAPK, BMP/Smad, and WNT/β-catenin signaling pathways, promoting osteoblast proliferation, differentiation, and mineralization<em> in vitro</em>. These findings highlight CWP’s dual role in enhancing bone formation and inhibiting resorption through both local (osteoblast activation) and systemic (hepatic-bone axis modulation) mechanisms. Collectively, CWP emerges as a promising multi-target therapeutic candidate for osteoporosis, bridging bone remodeling and metabolic crosstalk. Additional translational studies are warranted to validate its clinical efficacy.

Food Science and Human Wellness
National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province
Good health and well-being
Openalex Percentile: Top 96%
Animal health and immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.